People: Actelion Ltd (ATLN.VX)
Mr. Robert E. Cawthorn is Member of the Board of Directors at Actelion Ltd since September 27, 2011. Previously, he was Chairman of the Board of Directors of the Company from 2000 until September 26, 2011. He was Member of the Nominating and Governance Committee and Compensation Committee of the Company in 2009. During his career in the pharmaceutical industry, he established start-ups and has managed pharmaceutical companies. Following his retirement as Chairman and Chief Executive Officer (CEO) of Rhone-Poulenc-Rorer Inc, a position he held from 1985 till 1996, he was Managing Director of Global Health Care Partners, DLJ Merchant Banking, where he served from 1997 until 2001. After 17 years as Executive with Pfizer International, he became First President of Biogen and served at that company from 1979 till 1982. He joined the Rorer Group, in 1982, and as Chairman and CEO, led the transformation of that company from a small, primarily over-the-counter pharmaceutical company into research-driven company, culminating in the merger that created Rhone-Poulenc-Rorer. He is Member of the Board of Directors of The March Group. He is also Chairman of the Board of Directors of Biodesix Inc. Mr. Cawthorn graduated from the University of Cambridge with a Bachelors degree in Agriculture.
|Total Annual Compensation, CHF||Long-Term Incentive Plans, CHF||All Other, CHF||Fiscal Year Total, CHF|